Hotview Biotech (688068.SH) announced that as of the close of trading on February 19, 2024, the company passed centralized bidding...
Zhitong Finance App News, Hotview Biotech (688068.SH) announced that by the close of trading on February 19, 2024, the company had repurchased a total of 2,476,500 shares through centralized bidding transactions, accounting for 2.68% of the company's total share capital, an increase of 1.63% compared with the previous disclosure. The highest price of the repurchase transaction was 33.79 yuan/share, the lowest price was 27.28 yuan/share, and the total amount of capital paid was RMB 79.11 million (excluding transaction fees such as stamp duty and transaction fees).